CD8A and colorectal carcinoma: For instance, combining 2-DG with anti-PD-1 antibodies under a fasting-mimicking diet in CT26 CRC mouse models reduced intratumoral lactate levels and enhanced CD8+ T cell activation, resulting in significant tumor regression and prolonged survival.